Core Antimicrobial Stewardship Curriculum for Faculty

The IDSA Core Antimicrobial Stewardship (CAS) Curriculum was developed to provide infectious diseases (ID) fellows with foundational education and training in Antimicrobial
Stewardship (AS), regardless of ultimate career plans. The curriculum is designed for use within an existing ID fellowship training program to ensure the future ID workforce is equipped to oversee and participate in AS efforts.

The faculty version of the curriculum provides access to manage fellow completions and attendance, exclusive video content for classroom facilitation, and guidance on implementation. For additional details regarding faculty participation and the time commitment, please refer to the flyer at the bottom of this page.

Target Audience

This course is designed specifically for ID training program directors, ID Pharmacists, AS medical directors, the designated Antimicrobial Stewardship Champion or other faculty members that will be implementing the AS curriculum for stewards in training.

Learning Objectives

Upon completion of this Curriculum, the learner should be able to:

1. Explain to patients and health care providers the importance of antibiotic stewardship in the care of individual patients and the community at large

2. Model antibiotic stewardship best practices during the clinical care of patients in the inpatient and outpatient setting

3. Structure a conversation to effect change in the antibiotic prescribing patterns of other providers using techniques based in behavioral psychology

4. Describe elements of an effective antibiotic stewardship program and explain the inter-professional collaborations and leadership support necessary for its success

5. Discuss antibiotic stewardship as a potential career pathway and explain the day to day activities of the antibiotic steward

Additional Information

Course summary
Course opens: 
07/01/2021
Course expires: 
12/01/2022
IDSA Member cost:
$200.00
Non-member cost:
$300.00
Cost:
$300.00

AS Curriculum Workgroup COI Summary Reviewed April 2017 by Rachel Simmons, MD No conflicts found.

All relevant financial relationships have been mitigated.

NameIndividual's role in activityName of commercial interestNature of Relationship
Advani, SonaliWorkgroup MemberNone 
Armstrong, WendyWorkgroup MemberNone 
Barsoumian, AliceWorkgroup MemberNone 
Beeler, ColeWorkgroup MemberNone 
Bennani, KenzaStaffNone 
Blair, BarbraWorkgroup MemberNone 
Brennan - Krohn, TheaWorkgroup MemberNone 
Bryson - Cahn, ChloeWorkgroup MemberNone 
Cherabuddi, KartikWorkgroup MemberNone 
Fong, GaryWorkgroup MemberCritical Innovations, LLCAdvisory/Consultant Role
Gaston, DavidWorkgroup MemberNone 
Hamilton, KeithWorkgroup MemberNone 
Holubar, MarisaWorkgroup MemberNone 
Huang, MishaWorkgroup MemberNone 
Ince, DilekWorkgroup MemberGilead Science’s Clinical Studies for remdesivir Principal Investigator
  Accelerate DiagnosticsResearch Grants/Contracts
  LeidosResearch Grants/Contracts
Justo, Julie AnnWorkgroup MemberbioMerieuxOther remuneration - Speaker's Bureau
  MerckAdvisory/Consultant Role
  VaxartStocks/Bonds
Kang, AmyWorkgroup MemberNone 
Larnard, JeffWorkgroup MemberNone 
Lee, MatthewWorkgroup MemberNone 
Logan, AshleighStaffNone 
Luther, VeraWorkgroup MemberNone 
MacDougal, ConanWorkgroup MemberNone 
Melia, MichaelWorkgroup MemberMerckOrganizational Benefit
  AllerganOrganizational Benefit
  Pfizer; MelintaOrganizational Benefit
Miller, MattWorkgroup MemberAbbvieHonoraria
  La JollaHonoraria
  MerckResearch Grant/Contract
Moenster, RyanWorkgroup MemberShionogiAdvisory/Consultant Role, Honoraria
  Abbvie/AllerganAdvisory/Consultant Role, Honoraria
  Melinta TherapeuticsAdvisory/Consultant Role, Honoraria
  MerckAdvisory/Consultant Role, Honoraria
Nori, PriyaWorkgroup MemberMerckCo-infections in COVID-19 patients
Paras, MollyWorkgroup MemberNone 
Patel, PayalWorkgroup MemberNone 
Rodvold, KeithWorkgroup MemberBLC USA LPAdvisory/Consultant Role, Honoraria
  VenatoRxAdvisory/Consultant Role, Honoraria
  Medicine Company/Qpex BiopharmaAdvisory/Consultant Role, Honoraria
  Vemco Med Ed. (Merck CME/CPE programs)Advisory/Consultant Role, Honoraria
  DebipharmAdvisory/Consultant Role, Honoraria
  ShionogiAdvisory/Consultant Role, Honoraria
   Unrestricted education grant for CME/CPE Program
  Utility TherapeuticsAdvisory/Consultant Role, Honoraria
  JanssenData Safety Monitoring Board (DSMB)
  Clinartis LLC (projects associated with Spero Therapeutics and Sinovent)Advisory/Consultant Role, Honoraria
  USCAST : US Ctte on Antimicrobial Susceptibility TestingVoting Committee Member
Schooneveld, TrevorWorkgroup MemberRebiotix, MerkResearch Grant
  Thermo - FischerSpeaking
Schwartz, BrianWorkgroup MemberNone 
Spicer, JenniferWorkgroup MemberNone 
Stack, ConorWorkgroup MemberNone 
Stead, WendyWorkgroup MemberNone 
Stohs, EricaWorkgroup MemberReviral LtdResearch Grant
Wiley, ZanthiaWorkgroup MemberNone 
Willis, ZacharyWorkgroup MemberNone 
Shnekendorf, RachelStaffNone 

Vaezi, Liza

Workgroup MemberNone 
Rachel SimmonsReviewerNone 

 

 

This version of the curriculum is not accredited for CME or MOC.
 
Status
Price
Title
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.

Price

IDSA Member cost:
$200.00
Non-member cost:
$300.00
Cost:
$300.00
Please login or register to take this course.

Click here to visit the IDSA website to view full pricing information, along with available discounts.

Note: If you are purchasing on behalf of faculty and/or fellows/trainees, you can log in or create an account to complete the webform and finalize transaction.

Required Hardware/software

PCs Running Window

  • Windows 10  
  • Microsoft Edge
  • Firefox
  • Google Chrome

Apple Computers Running OSX

  • Safari
  • Firefox
  • Google Chrome